MATT RAMSEY: Open Payments
NPI 1699261099 · JACKSON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,887 in 86 payments from 19 companies in 2025. Trend: 2023 $932 · 2024 $1,526 · 2025 $1,887
Food & beverage: $1,887
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $367 |
| Biogen, Inc. | 12 | $260 |
| SK Life Science, Inc. | 7 | $183 |
| UCB, Inc. | 5 | $167 |
| Eisai Inc. | 8 | $163 |
| Lundbeck LLC | 5 | $106 |
| ARGENX US, INC. | 4 | $90 |
| Otsuka America Pharmaceutical, Inc. | 4 | $84 |
| Teva Pharmaceuticals USA, Inc. | 4 | $81 |
| TG Therapeutics, Inc. | 2 | $61 |
Products named: KESIMPTA, VUMERITY, Leqembi, Rystiggo, VYEPTI, VYVGART HYTRULO, REXULTI, BRIUMVI.
Industry payments across TN — which companies pay providers there.
